HRMY vs REG · P/E 14, rev $476.7M vs P/E 34, rev $1.45B
Harmony Biosciences Holdings (HRMY) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
HRMY currently screens at market cap $1.96B and trailing P/E 13.6. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the HRMY and REG stock pages for the full models.
Not investment advice.